These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36717650)

  • 41. [Ressarch Advances of Prevantive and Therapeatic Effect of Mesenchymal Stromal Cells on Graft-Versus-Host Disease--Review].
    Wang L; Ma DX; Liu SF; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):283-287. PubMed ID: 30738484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
    Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
    Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.
    Olson JA; Zeiser R; Beilhack A; Goldman JJ; Negrin RS
    J Immunol; 2009 Sep; 183(5):3219-28. PubMed ID: 19657090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
    Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T
    Front Immunol; 2018; 9():2666. PubMed ID: 30515159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesenchymal stromal cells: a new tool against graft-versus-host disease?
    Baron F; Storb R
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):822-40. PubMed ID: 21963621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model.
    Lee ES; Lim JY; Im KI; Kim N; Nam YS; Jeon YW; Cho SG
    PLoS One; 2015; 10(9):e0138846. PubMed ID: 26393514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats.
    Xia X; Chen W; Ma T; Xu G; Liu H; Liang C; Bai X; Zhang Y; He Y; Liang T
    Liver Transpl; 2012 Jun; 18(6):696-706. PubMed ID: 22344929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft
    Chinnadurai R; Bates PD; Kunugi KA; Nickel KP; DeWerd LA; Capitini CM; Galipeau J; Kimple RJ
    Front Immunol; 2021; 12():708950. PubMed ID: 34386012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties.
    Neo SH; Her Z; Othman R; Tee CA; Ong LC; Wang Y; Tan I; Tan J; Yang Y; Yang Z; Chen Q; Boyer LA
    Stem Cell Res Ther; 2023 Sep; 14(1):259. PubMed ID: 37726837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of lentiviral vector mediated CXCR4 gene overexpressed mesenchymal stem cell on the protection of mice against graft-versus-host disease].
    Chen W; Li M; Zhang C; Wang X; Pan B; Zeng L; Li Z; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):936-40. PubMed ID: 25339334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.
    Nishi Y; Murakami A; Murayama Y; Tsukahara N; Okamoto S; Nakachi S; Morichika K; Tamaki K; Noguchi H; Matsushita M; Karube KN; Fukushima T; Morishima S; Kishimoto H; Masuzaki H
    Transpl Immunol; 2019 Aug; 55():101205. PubMed ID: 30946889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current basic understanding and clinical application of mesenchymal stromal/stem cells].
    Miura Y
    Rinsho Ketsueki; 2018; 59(10):1935-1941. PubMed ID: 30305494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease.
    Chen W; Li M; Li Z; Yan Z; Cheng H; Pan B; Cao J; Chen C; Zeng L; Xu K
    Immunol Lett; 2012 Apr; 143(2):161-9. PubMed ID: 22342854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
    Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
    Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of marrow derived mesenchymal stem cells in the prevention and treatment of acute graft-versus-host in mice.].
    Bao XC; Wang JM; Zhang WP; Zhou H; Zheng XL; Gao L
    Zhonghua Xue Ye Xue Za Zhi; 2010 Feb; 31(2):108-13. PubMed ID: 20302798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging therapeutic approaches for multipotent mesenchymal stromal cells.
    Caimi PF; Reese J; Lee Z; Lazarus HM
    Curr Opin Hematol; 2010 Nov; 17(6):505-13. PubMed ID: 20729733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.
    Morata-Tarifa C; Macías-Sánchez MDM; Gutiérrez-Pizarraya A; Sanchez-Pernaute R
    Stem Cell Res Ther; 2020 Feb; 11(1):64. PubMed ID: 32070420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.